|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.54 CHF | +1.98% |
|
+2.55% | +14.54% |
| 07-21 | Healthcare Shares Rise -- Healthcare Roundup | DJ |
| 07-21 | Novartis CEO on 2Q Profit Beat, Investing in Pipeline | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 21.23x | 6.12x | -28.49x | 5.45x | 13.2x | 14.43x | 2.93% | 278B | ||
| 34.09x | 20.8x | 0.73x | 12.2x | 25.51x | 26.47x | 0.59% | 1,023B | ||
| 26.74x | 6.69x | -1.71x | 6.1x | 16.7x | 18.36x | 2.16% | 599B | ||
| 33.01x | 12612.24x | 0.15x | 7.5x | 15.37x | 15.88x | 2.71% | 448B | ||
| 17.72x | 6.56x | 1.06x | 4.39x | 10.82x | 12.17x | 3.02% | 326B | ||
| 20.75x | 4.86x | 0.93x | 4.38x | 12.12x | 13.1x | 2.01% | 258B | ||
| 14.46x | 6.39x | -9.41x | 5.38x | 11.08x | 13.03x | 3.46% | 222B | ||
| 23.89x | 18.37x | 3.34x | 6.31x | 11.13x | 14.44x | 2.77% | 197B | ||
| -47.99x | 8.41x | 0.34x | 5.74x | 31.73x | 63.5x | 2.44% | 165B | ||
| 12.57x | 1.6x | 0.28x | 3.08x | 7.79x | 8.81x | 6.97% | 141B | ||
| 11.68x | 5.28x | 0.24x | 3.2x | 8.62x | 9.27x | 4.19% | 123B | ||
| 27.39x | 5.5x | 1.89x | 8.29x | 18.69x | 19.59x | -.--% | 122B | ||
| 11.61x | 1.23x | 3.28x | 2.18x | 6.98x | 8x | 5.53% | 105B | ||
| 11.86x | 4.34x | 0.95x | 2.67x | 7.74x | 8.85x | 3.7% | 101B | ||
| 23.69x | 5.37x | 1.37x | 8.02x | 15.16x | 15.87x | 1.87% | 74.16B | ||
| 20.45x | 1.66x | -0.13x | 1.72x | 8.15x | 13.68x | 0.48% | 53.03B | ||
| 44.1x | 1.18x | 23.67x | 2.71x | 9.57x | 27.38x | 3.73% | 53.26B | ||
| 39.79x | 5.36x | 2.17x | 9.06x | 29.97x | 33.27x | 0.48% | 54.1B | ||
| 19.16x | 1.93x | 4.09x | 3.47x | 13.04x | 14.63x | 2.15% | 43.86B | ||
| Average | 19.27x | 669.68x | 0.25x | 5.36x | 14.39x | 18.46x | 2.69% | 230.81B | |
| Weighted average by Cap. | 22.76x | 1,296.56x | -1.49x | 7.01x | 16.74x | 19.40x | 2.3% |
- Stock Market
- Stocks
- NOVN Stock
- Sector Novartis AG
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















